POSTEC 2,5 MG + 150 UTR POM DERM CT BG AL X 10 G

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1011801640017
  • GGREM 501602201160313
  • Código de barras 7896637023078

O que a fonte publica

Detentor do registro
APSEN FARMACEUTICA S/A
Princípios ativos
VALERATO DE BETAMETASONA;HIALURONIDASE
Embalagem
2,5 MG + 150 UTR POM DERM CT BG AL X 10 G
Tipo de produto
Novo
Classe terapêutica
D7B4 - OUTRAS ASSOCIAÇÕES DE CORTICOSTERÓIDES

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:501602201160313
{
  "name": "POSTEC 2,5 MG + 150 UTR POM DERM CT BG AL X 10 G",
  "holder": "APSEN FARMACEUTICA S/A",
  "stripe": null,
  "barcodes": [
    "7896637023078"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "501602201160313",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "62.462.015/0001-29",
  "priceRegime": "Regulado",
  "productName": "POSTEC",
  "productType": "Novo",
  "hospitalOnly": false,
  "presentation": "2,5 MG + 150 UTR POM DERM CT BG AL X 10 G",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "48.34",
    "icms-12": "54.93",
    "icms-17": "58.24",
    "icms-18": "58.95",
    "icms-19": "59.68",
    "icms-20": "60.43",
    "icms-21": "61.19",
    "icms-22": "61.97",
    "icms-23": "62.78",
    "icms-17.5": "58.59",
    "icms-19.5": "60.05",
    "icms-20.5": "60.81",
    "icms-22.5": "62.37",
    "icms-12-alc": "49.05",
    "icms-17-alc": "52.00",
    "icms-18-alc": "52.64",
    "icms-19-alc": "53.28",
    "icms-20-alc": "53.95",
    "icms-21-alc": "54.63",
    "icms-22-alc": "55.33",
    "icms-23-alc": "56.05",
    "withoutTaxes": "43.16",
    "icms-17.5-alc": "52.32",
    "icms-19.5-alc": "53.62",
    "icms-20.5-alc": "54.29",
    "icms-22.5-alc": "55.69"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "VALERATO DE BETAMETASONA;HIALURONIDASE",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "64.85",
    "icms-12": "73.69",
    "icms-17": "78.13",
    "icms-18": "79.08",
    "icms-19": "80.06",
    "icms-20": "81.06",
    "icms-21": "82.08",
    "icms-22": "83.13",
    "icms-23": "84.22",
    "icms-17.5": "78.60",
    "icms-19.5": "80.55",
    "icms-20.5": "81.57",
    "icms-22.5": "83.67",
    "icms-12-alc": "67.81",
    "icms-17-alc": "71.89",
    "icms-18-alc": "72.77",
    "icms-19-alc": "73.66",
    "icms-20-alc": "74.58",
    "icms-21-alc": "75.52",
    "icms-22-alc": "76.49",
    "icms-23-alc": "77.49",
    "withoutTaxes": "59.67",
    "icms-17.5-alc": "72.33",
    "icms-19.5-alc": "74.13",
    "icms-20.5-alc": "75.05",
    "icms-22.5-alc": "76.99"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "VALERATO DE BETAMETASONA",
    "HIALURONIDASE"
  ],
  "therapeuticClass": "D7B4 - OUTRAS ASSOCIAÇÕES DE CORTICOSTERÓIDES",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1011801640017",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "D7B4",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:501602201160313"